Cargando…
Rational selection of a biomarker panel targeting unmet clinical needs in kidney injury
The pipeline of biomarker translation from bench to bedside is challenging and limited biomarkers have been adopted to routine clinical care. Ideally, biomarker research and development should be driven by unmet clinical needs in health care. To guide researchers, clinical chemists and clinicians in...
Autores principales: | van Duijl, T. T., Soonawala, D., de Fijter, J. W., Ruhaak, L. R., Cobbaert, C. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898424/ https://www.ncbi.nlm.nih.gov/pubmed/33618665 http://dx.doi.org/10.1186/s12014-021-09315-z |
Ejemplares similares
-
Development and
Provisional Validation of a Multiplex
LC-MRM-MS Test for Timely Kidney Injury Detection in Urine
por: van Duijl, Tirsa T., et al.
Publicado: (2021) -
The Time Has Come for Quantitative Protein Mass Spectrometry
Tests That Target Unmet Clinical Needs
por: Smit, Nico P. M., et al.
Publicado: (2021) -
The predictive value of TIMP-2 and IGFBP7 for kidney failure and 30-day mortality after elective cardiac surgery
por: Esmeijer, Kevin, et al.
Publicado: (2021) -
Practical guide for identifying unmet clinical needs for biomarkers
por: Monaghan, Phillip J., et al.
Publicado: (2018) -
Urinary Tissue Inhibitor of Metalloproteinases-2 and Insulin-Like Growth Factor–Binding Protein 7 Do Not Correlate With Disease Severity in ADPKD Patients
por: Dekker, Shosha E.I., et al.
Publicado: (2019)